happytrader1543

SVRA BIO TECH Long

Long
NASDAQ:SVRA   Savara, Inc
Sector: Health Technology
Industry: Biotechnology
Savara , Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX .

Market Capitalization
115.522M

Total Shares Outstanding ( MRQ )
54.236M

Net Debt ( MRQ )
-56.821M

Total Assets ( MRQ )
97.745M

Revenue per Employee ( TTM )
9518.5185

Free Cash Flow ( TTM )
-39.883M :(, but it's BIO and other indicators look good.

Phase 2-3 trials, FDA looking at turning decision from June that scared off investors.

Analyst upgrade to 7
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.